Srcasm inhibits Fyn-induced cutaneous carcinogenesis with modulation of Notch1 and p53.

Source:http://linkedlifedata.com/resource/pubmed/id/19934324

Cancer Res. 2009 Dec 15 69 24 9439-47

Download in:

View as

Triples

General Info

PMID
19934324